Globus Medical Q3 Non-GAAP Earnings Rise, Revenue Falls

04:59 PM EST, 11/05/2026 (MT Newswires) -- Globus Medical (GMED) reported Q3 non-GAAP earnings late Thursday of $1.23 per diluted share, up from $1.18 a year earlier. Analysts polled by FactSet expected $1.20. Revenue for the quarter ended Sept. 30 was $763.7 million, down from $769.0 million a year ago. Analysts surveyed by FactSet expected $792.4 million. The company reaffirmed its full-year 2026 non-GAAP diluted EPS guidance of $4.95 to $5.05. Analysts polled by FactSet expect $5.00 per share. The company expects full-year 2026 revenue of $3.09 billion, compared with previous guidance of $3.18 billion to $3.22 billion. Analysts polled by FactSet expect $3.20 billion.